Passage Bio Analyst Ratings
Enlivex Therapeutics Announces Investor Webinar To Discuss Interim Data From Phase I/II Allocetra Trial In Knee Osteoarthritis On March 5, 2025, At 11:00 A.m. ET
Contineum Therapeutics Initiates Patient Dosing In Phase 1b Chronic Pain Trial Of PIPE-791
Earnings Call Summary | Wave Life Sciences(WVE.US) Q4 2024 Earnings Conference
Earnings Call Summary | Y-mAbs Therapeutics(YMAB.US) Q4 2024 Earnings Conference
Amazon Drops Into Oversold Territory for the First Time in 7 Months